Cediranib for alveolar soft part sarcoma: a randomised study in relation to clinical practice

Sandro Pasquali; Silvia Stacchiotti

doi:10.1016/S1470-2045(19)30324-9

Cediranib for alveolar soft part sarcoma: a randomised study in relation to clinical practice

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	901-903
Number of pages	3
Journal	The Lancet Oncology
Volume	20
Issue number	7
DOIs	https://doi.org/10.1016/S1470-2045(19)30324-9
Publication status	Published - Jul 2019

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(19)30324-9

Cite this

@article{ab0a49a117694e679fb34c33269a8291,

title = "Cediranib for alveolar soft part sarcoma: a randomised study in relation to clinical practice",

author = "Sandro Pasquali and Silvia Stacchiotti",

year = "2019",

month = jul,

doi = "10.1016/S1470-2045(19)30324-9",

language = "English",

volume = "20",

pages = "901--903",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "7",

}

TY - JOUR

T1 - Cediranib for alveolar soft part sarcoma

T2 - a randomised study in relation to clinical practice

AU - Pasquali, Sandro

AU - Stacchiotti, Silvia

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85068085053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068085053&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(19)30324-9

DO - 10.1016/S1470-2045(19)30324-9

M3 - Comment/debate

C2 - 31160250

AN - SCOPUS:85068085053

VL - 20

SP - 901

EP - 903

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 7

ER -

Cediranib for alveolar soft part sarcoma: a randomised study in relation to clinical practice

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this